Acasti Pharma Inc EV/EBIT
What is the EV/EBIT of Acasti Pharma Inc?
The EV/EBIT of Acasti Pharma Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Acasti Pharma Inc
What does Acasti Pharma Inc do?
acasti pharma, inc., a subsiduary of neptune technologies & bioressources, is a quebec-based biopharmaceutical dedicated in advancing a proprietary portfolio based on marine phospholipids. our products can be used in prescription, medical food and over-the-counter applications, either as a stand-alone, or, as a fixed-dose combination to exisitng productrs, for the prevention and treatment of cardiometabolic disorders.
Companies with ev/ebit similar to Acasti Pharma Inc
- Halo Collective has EV/EBIT of N/A
- Nkarta has EV/EBIT of N/A
- Manugraph India has EV/EBIT of N/A
- Guild Esports Plc has EV/EBIT of N/A
- Clarity Gold has EV/EBIT of N/A
- Radha Madhav has EV/EBIT of N/A
- Acasti Pharma Inc has EV/EBIT of N/A
- Akers Biosciences Inc has EV/EBIT of N/A
- Agios Pharmaceuticals Inc has EV/EBIT of N/A
- Generation Bio Co has EV/EBIT of N/A
- Purple Biotech has EV/EBIT of N/A
- Panbela Therapeutics has EV/EBIT of N/A
- Continental Materials has EV/EBIT of N/A